254 related articles for article (PubMed ID: 22151412)
1. A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.
Ditisheim S; Giostra E; Burkhard PR; Goossens N; Mentha G; Hadengue A; Spahr L
BMC Gastroenterol; 2011 Dec; 11():134. PubMed ID: 22151412
[TBL] [Abstract][Full Text] [Related]
2. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
[TBL] [Abstract][Full Text] [Related]
3. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Grande L; Camacho I
Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.
Senzolo M; Zarantonello L; Formentin C; Orlando C; Beltrame R; Vuerich A; Angeli P; Burra P; Montagnese S
Metab Brain Dis; 2019 Dec; 34(6):1803-1812. PubMed ID: 31506797
[TBL] [Abstract][Full Text] [Related]
6. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Grande L; Camacho I; Benitez S; Irles JA; Castro M
J Hepatol; 2002 Dec; 37(6):781-7. PubMed ID: 12445419
[TBL] [Abstract][Full Text] [Related]
7. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
[TBL] [Abstract][Full Text] [Related]
8. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
[TBL] [Abstract][Full Text] [Related]
9. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
Oppong KN; Al-Mardini H; Thick M; Record CO
Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307
[TBL] [Abstract][Full Text] [Related]
10. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
Formentin C; De Rui M; Zoncapè M; Ceccato S; Zarantonello L; Senzolo M; Burra P; Angeli P; Amodio P; Montagnese S
J Hepatol; 2019 Apr; 70(4):648-657. PubMed ID: 30633946
[TBL] [Abstract][Full Text] [Related]
11. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
[TBL] [Abstract][Full Text] [Related]
12. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
[TBL] [Abstract][Full Text] [Related]
13. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
Kircheis G; Hilger N; Häussinger D
Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
[TBL] [Abstract][Full Text] [Related]
14. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
[TBL] [Abstract][Full Text] [Related]
15. How to diagnose hepatic encephalopathy in the emergency department.
Gundling F; Zelihic E; Seidl H; Haller B; Umgelter A; Schepp W; Dodt C
Ann Hepatol; 2013; 12(1):108-14. PubMed ID: 23293201
[TBL] [Abstract][Full Text] [Related]
16. Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study.
Koziarska D; Wunsch E; Milkiewicz M; Wójcicki M; Nowacki P; Milkiewicz P
BMC Gastroenterol; 2013 Jul; 13():107. PubMed ID: 23815160
[TBL] [Abstract][Full Text] [Related]
17. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
Montagnese S; Biancardi A; Schiff S; Carraro P; Carlà V; Mannaioni G; Moroni F; Tono N; Angeli P; Gatta A; Amodio P
Hepatology; 2011 Feb; 53(2):558-66. PubMed ID: 21274876
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
19. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
20. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
